Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Concurrent use of benzodiazepines and psychotherapy for panic disorder is a prevalent but highly controversial practice. Although there are many rationales for that approach, critics contend that benzodiazepines foster drug abuse and dependence and undermine psychosocial treatments in various ways. The authors examine that controversy in the light of recent empirical findings and offer some tentative conclusions and recommendations. METHOD: Data from studies combining benzodiazepines and the leading psychosocial treatment for panic disorder, exposure-based cognitive behavior therapy, are reviewed, and their application to clinical practice is discussed. RESULTS: The strongest support for combined treatment is for the addition of cognitive behavior therapy to pharmacotherapy for patients with agoraphobia and for those whose benzodiazepine treatment is being discontinued. The greatest problem with combined treatment is relapse after drug discontinuance. CONCLUSIONS: Combined treatment may be advantageous for some patients, but it must be carefully designed to avoid potential problems. Suggestions for that are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clark, D. M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90011-2 · Cited by 2,422
Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.759 · Cited by 673
A meta-analysis of treatment outcome for panic disorder
Gould, R. A., Ott, M. W., & Pollack, M. H. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)00048-8 · Cited by 520
Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478
Psychological treatment of panic: Work in progress on outcome, active ingredients, and follow-up
Margraf, J., Barlow, D. H., Clark, D. M., & Telch, M. J. (1993) · Behaviour Research and Therapy · doi:10.1016/0005-7967(93)90036-t · Cited by 377
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.10.1485 · Cited by 263
Brown, T. A., & Barlow, D. H. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.5.754 · Cited by 262
Behavioral treatment of panic disorder: A two-year follow-up
Craske, M. G., Brown, T. A., & Barlow, D. H. (1991) · Behavior Therapy · doi:10.1016/s0005-7894(05)80367-3 · Cited by 258
Does Cognitive Behavior Therapy Assist Slow-Taper Alprazolam Discontinuation in Panic Disorder?
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.876 · Cited by 153
Self-citation(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.683 · Cited by 144
Cited by
van der Kolk, B. A., Spinazzola, J., Blaustein, M. E., Hopper, J. W., Hopper, E. K., Korn, D. L., & Simpson, W. B. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0105 · Cited by 399
Freedland, K. E., Mohr, D. C., Davidson, K. W., & Schwartz, J. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318218e1fb · Cited by 369
“For example, benzodiazepines may interfere with behavioral interventions for anxiety disorders (45,46).”
BackgroundThe reappraisal of benzodiazepines in the treatment of anxiety and related disorders
Starcevic, V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.963057 · Cited by 90
“It has been a long-standing assumption that BDZs interfere with CBT and that they should generally be avoided in patients with anxiety disorders undergoing CBT [36], although the evidence supporting this assumption has been equivocal [37–39].”
ResultBruce, T. J., Spiegel, D. A., & Hegel, M. T. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.1.151 · Cited by 69
“Of course, other considerations may be involved as well (cf. Spiegel & Bruce, 1997 ).”
BackgroundSelf-citationFixsen, A. M. (2016) · Qualitative Health Research · doi:10.1177/1049732315576496 · Cited by 17
“Once dependency occurs, withdrawal can be a protracted and distressing process (Ashton, 2005; Lader, 2012; Spiegel & Bruce, 1997).”
BackgroundThe Current Role of Long-Term Benzodiazepines for the Treatment of Generalized Anxiety
(2015) · Osteopathic Family Physician · doi:10.1016/ofp.v7i1.364 · Cited by 10
Psychotherapy for Perinatal Mood and Anxiety Disorders
Schiller, C. E., Thompson, K., Cohen, M. J., Geiger, P., Lundegard, L., & Bonacquisti, A. (2021) · Women's Mood Disorders · doi:10.1007/978-3-030-71497-0_17 · Cited by 4
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1997-06-01
- Volume
- 154
- Issue
- 6
- Pages
- 773-781
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2418449582
- Cited by
- 66
- References
- 14
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.